ExploreWatchlistsPricing
  1. US-listed companies
  2. ALNYLAM PHARMACEUTICALS, INC.
  3. Financials
  4. FCF margin (%)

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Market cap
$40.9B
P/E ratio
132.4x
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 202512.5-761.49%
Dec 31, 2024-1.9-182.57%
Dec 31, 20232.3-103.88%
Dec 31, 2022-59.1-30.49%
Dec 31, 2021-85-38.84%
Dec 31, 2020-139.1-27.00%
Dec 31, 2019-190.5-79.31%
Dec 31, 2018-920.5+933.81%
Dec 31, 2010-89

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat